Created by potrace 1.16, written by Peter Selinger 2001-2019beatandraise.com
Latest Financials

Filings:

CategoryDateSearch FilingsInstitutional HoldersbetaEarnings TranscriptsbetaGlobal Search

SEC Edgar

NYMOX PHARMACEUTICAL CORP

SIC 2835 · In Vitro & In Vivo Diagnostic Substances
NotesSupport
aboutterms
$NYMXF

NYMOX PHARMACEUTICAL CORP

CIK:0001018735|SEC Filings

INDENTURES

EX-4.1
nymox_ex41.htm
Mar 22, 2022
EX-4.2
nymox_ex42.htm
Mar 22, 2022
EX-4.1
nymox_ex41.htm
May 6, 2021
EX-4.2
nymox_ex42.htm
May 6, 2021
EX-4.W
exhibit4-w.htm
Mar 31, 2016
EX-4.X
exhibit4-x.htm
Mar 31, 2016
EX-4.Y
exhibit4-y.htm
Mar 31, 2016
EX-4.X
exhibit4-x.htm
Mar 31, 2015
EX-4.W
exhibit4-w.htm
Mar 14, 2014
EX-4.V
exhibit4-v.htm
Mar 15, 2013
EX-4.U
exhibit4-u.htm
Mar 15, 2012
EX-4.S
exhibit4-s.htm
Jun 3, 2011
EX-4.T
exhibit4-t.htm
Jun 3, 2011
EX-4.(N)
dbk181e.htm
Jun 30, 2006
EX-4.(J)
slp315a.txt
Jun 27, 2002